This study is an important first step toward the development of a pigment epithelial cell-based BDNF gene therapy that could be used as an advanced therapy medicinal product (ATMP) for the treatment of neurodegenerative eye diseases. The gene discussed is BDNF; the disease is eye degenerative disorder.